The use of recombinant interferon-alpha preparations for the combined treatment of genital papillomaviris infection

Bagramova G.É.; Gureeva M.A.; Khlebnikova A.N.; Molochkov A.V.

doi:https://doi.org/

Bagramova G.É.

FPKMR RUDN, Moskva

Gureeva M.A.

FPKMR RUDN, Moskva

Khlebnikova A.N.

I.M. Sechenov Moscow Medical Academy

Scopus AuthorID: 6507373964
ORCID: 0000-0003-4400-5631

Molochkov A.V.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr khirurgii im. akad. B.V. Petrovskogo" RAMN, Moskva

The use of recombinant interferon-alpha preparations for the combined treatment of genital papillomaviris infection

Authors:

Bagramova G.É., Gureeva M.A., Khlebnikova A.N., Molochkov A.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2012;10(1): 24‑28

Read: 8104 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Bagramova GÉ, Gureeva MA, Khlebnikova AN, Molochkov AV. The use of recombinant interferon-alpha preparations for the combined treatment of genital papillomaviris infection. Russian Journal of Clinical Dermatology and Venereology. 2012;10(1):24‑28. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

References:

Kirnbauer R., Lenz P., Okun M.M. Human papilllomavirus. In: Dermatology. Ed: J.L. Bolognia et al. Edinburg Mosby 2002; 1217-1234.
Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 2000; 19: 1-2: 1-90.
zur Hauzen H. Papillomavirus infection: a major cause of human cancer. Byochem Biophys Acta 1996; 1288: 2: F.55-F.78.
Evstigneeva N.P. Papillomavirusnaya infektsiya urogenital'nogo trakta zhenshchin: epidemiologiya, faktory persistentsii, optimizatsiya rannei diagnostiki i profilaktiki onkogeneza: Avtoref. dis. ... d-ra med. nauk. M 2007.
Kiselev V.I. Virusy papillomy cheloveka v razvitii raka sheiki matki. M 2004.
Dmitriev G.A., Bitkina O.A. Papillomavirusnaya infektsiya. M: Meditsinskaya kniga 2006.
Allen A.L., Siegfried E.C. What's new in human papillomavirus infection. Curr Opin Pediatr 2000; 12: 4: 365-399.
Davydov M., Demidov L., Polyakov V. Sovremennoe sostoyanie i problemy onkologii. Vrach 2007; 13: 3-7.
Benton S., Shahidullah H., Hunter J.A.A. Human papillomavirus in the immunosuppressed. Papillomavirus Rep 1992; 3: 23-26.
Palefsky J.M. Anal sguamous cell intraepithelial lesions: relation to HIV and human papillomavirus infection. J Acquir Immun Defic Syndr 1999; 21: Suppl 1: 42-48.
Tagami H. Regression phenomenon of numerous flat wars: an experiment on the nature of tumor immunity in man. Int J Dermatol 1983; 22: 10: 570-571.
Brandsma J.L. Animal models for HPV vaccine development. Papillomavirus Rep 1994; 5: 105-111.
Kiselev V.I., Kiselev O.I. Virusy papillomy cheloveka v razvitii raka sheiki matki. SPb-M 2003.
Munger K., Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 2: 213-228.
Berman B., Ramires C.C. Anogenital warts. Treatment of Skin Disease. Compehansive therapeutic strategies. Eds. M.G. Lebwohl et al. 2 ed. 2006; 47-49.
Koutsky L.A., Kiviar N.B. Genital human papilomavirus. In: Sexual Transmitted Diseases. Eds. K.K. Holmes et al. 3 ed. New York 1999; 347-360.
Delenyan N.V., Arinenko E.N., Meshkova E.N. i dr. Viferon. Rukovodstvo dlya vrachei. Pod red. V.V. Malinovskoi. M 1997.
Dzhumingo P.A. Interferonoobrazovanie i produktsiya spetsificheskikh antitel v protsesse kombinirovannoi terapii reaferonom i antioksidantami u bol'nykh prostym retsidiviruyushchim gerpesom: Avtoref. dis. … kand. med. nauk. M 1990.
Ershov F.I. Sistema interferona v norme i pri patologii. M: Meditsina 1996.